Ireland - Financial Media Contact
Powerscourt
Tel: +353 (0)1 536 0682
2023 Interim Report
RNS Announcements
Investee Companies
Fri, 15 Sep 2023
Holding(s) in Company
Wed, 06 Sep 2023
Interim Results 2023
Wed, 16 Aug 2023
Notice of 2023 Interim Results
Wed, 05 Jul 2023
Leadership Update
Wed, 24 May 2023
Director/PDMR Shareholding
News Archive>
02 Aug 2023
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline
27 Jun 2023
Kymab successor company, Sanofi, announces positive topline Phase 2b data in atopic dermatitis for amlitelimab (KY1005)
15 Nov 2022
CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline
28 Apr 2022
FDA Approves Mycovia Pharmaceuticals’ VIVJOA™ (oteseconazole), the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)
27 Jan 2022
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
